<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30099">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01904617</url>
  </required_header>
  <id_info>
    <org_study_id>025-11</org_study_id>
    <nct_id>NCT01904617</nct_id>
  </id_info>
  <brief_title>Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas</brief_title>
  <official_title>A Randomized Controlled Trial on the Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MemorialCare Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MemorialCare Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial aims to compare three groups of intravenous fluids and
      their impact on labor: 1) 125 mL/hr of 5% dextrose in normal saline 2) 250 mL/hr of normal
      saline 3) 250 mL/hr of 5% dextrose in normal saline
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Currently, patients who arrive to labor and delivery automatically receive IV fluid
      hydration as part of a standard order set.  The current default IV fluid order is 125mL/hr
      of 5% dextrose, either in normal saline or lactated ringers.

      Any patient delivering for the first time presenting to labor and delivery in active labor
      will be screened.  If they meet inclusion requirements they will be offered enrollment.

      Subjects will be blindly randomized to receive one of three different types of IV fluids:

        1. 5% dextrose Normal saline (Normal saline plus 5g/dl of glucose) at 125 mL/hr (the
           current LBMMC default inpatient IV order set)

        2. Normal saline (a solution containing sodium and chloride) at 250 mL/hr

        3. 2.5% dextrose Normal saline at 125 mL/hr

             -  Management of labor will be at the discretion of the attending physician(s).

             -  Maternal outcomes to be measured include: 1) total amount of IV fluids
                administered, 2) length of labor, 3) epidural use, 4) oxytocin use, 5) mode of
                delivery, 6) development of maternal infections or other morbidity such as
                postpartum hemorrhage.

             -  Neonatal outcomes to be measured include: 1) birth weight, 2) Apgar scores,  3)
                hospital course (nursery placement and length of stay), 4) need for treatment of
                jaundice.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Length of labor</measure>
    <time_frame>Time from fluid initiation to delivery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of second stage of labor</measure>
    <time_frame>Time from initiation of pushing to delivery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Length of Labor</condition>
  <condition>Second Stage of Labor</condition>
  <condition>Intravenous Hydration of Labor</condition>
  <arm_group>
    <arm_group_label>D5NS at 125 mL/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5% dextrose in normal saline at 125 mL/hr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D2.5NS at 250mL/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.5% dextrose in normal saline at 250 mL/hr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NS at 250mL/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal saline at 250mL/hr</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dextrose</intervention_name>
    <arm_group_label>D5NS at 125 mL/hr</arm_group_label>
    <arm_group_label>D2.5NS at 250mL/hr</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <arm_group_label>D5NS at 125 mL/hr</arm_group_label>
    <arm_group_label>D2.5NS at 250mL/hr</arm_group_label>
    <arm_group_label>NS at 250mL/hr</arm_group_label>
    <other_name>Intravenous fluids, normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Primiparous

               -  Singleton gestation

               -  Vertex presentation

               -  Spontaneous active labor with or without pitocin augmentation

               -  Gestational age &gt; 36 weeks

               -  Cervical dilation 3 to 5 cm with or without ruptured membranes

        Exclusion Criteria:

          -  • Multiparous

               -  Pregestational or gestational diabetes mellitus

               -  Preeclampsia at admission

               -  Previous cesarean section

               -  Non-vertex presentation

               -  Multiple gestation

               -  Chorioamnionitis at admission

               -  Intrauterine growth restriction (&lt; 10th percentile)

               -  Patients admitted for induction

               -  BMI &gt; 50
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vineet Shrivastava, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Long Beach Memorial Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Deysi Caballero, LVN</last_name>
    <phone>562-933-2755</phone>
    <email>dcaballero@memorialcare.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deysi Caballero, LVN</last_name>
      <phone>562-933-2755</phone>
      <email>dcaballero@memorialcare.org</email>
    </contact>
    <investigator>
      <last_name>Vineet Shrivastava, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 27, 2014</lastchanged_date>
  <firstreceived_date>April 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Length of labor</keyword>
  <keyword>second stage of labor</keyword>
  <keyword>intravenous hydration of labor</keyword>
  <keyword>intravenous glucose</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
